Recent Quotes (30 days)

You have no recent quotes
chg | %

BTG plc news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

BTG 795.00 +3.00 (0.38%)
price chart
3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and ...
Back in February last year I penned an article titled David & Goliath: AstraZeneca versus Hikma Pharmaceuticals, which compared the prospects of the two firms and suggested that looking down the food chain in the pharmaceutical sector could produce an ...
Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement ...
Investor sentiment in the pharmaceutical sector has weakened considerably in recent days after AbbVie decided to ditch its bid for Shire (LSE: SHP) (NASDAQ: SHPG.
Related articles »  
Investment Analysts' Recent Ratings Updates for BTG plc (BTG)
1/15/2015 - BTG plc had its price target raised by analysts at Investec from GBX 832 ($12.59) to GBX 1,135 ($17.18). They now have a �buy� rating on the stock.
5 Stunning Pharma Stocks: GlaxoSmithKline plc, AstraZeneca plc, Shire PLC ...
Of course, when it comes to profit growth, sector peer BTG (LSE: BTG) is very tough to beat. Certainly, it may trade on an exceptionally high P/E ratio of 52.5 but, with its earnings forecast to rise by a whopping 38% in the next financial year ...
JPMorgan Chase & Co. Reaffirms "Overweight" Rating for BTG plc
JPMorgan Chase & Co. restated their overweight rating on shares of BTG plc (LON:BTG) in a report released on Friday. JPMorgan Chase & Co.
BTG plc Stock Rating Reaffirmed by JPMorgan Chase & Co.  Ticker Report
BTG plc's Overweight Rating Reaffirmed at JPMorgan Chase & Co.  The Legacy
BTG plc's Overweight Rating Reiterated at JPMorgan Chase & Co. (BTG)
BTG has been the subject of a number of other recent research reports. Analysts at Deutsche Bank raised their price target on shares of BTG plc from GBX 790 ($12.42) to GBX 1,000 ($15.72) in a research note on Tuesday, December 9th. They now have a ...
Jefferies Group Boosts BTG plc Price Target to GBX 950 (BTG)  Mideast Time
Related articles »  
PneumRx Acquired by BTG plc for up to $475 Million
MOUNTAIN VIEW, California, Dec. 4, 2014 /PRNewswire/ -- PneumRx, Inc. (, a leader in the field of interventional pulmonology, today announced that it has signed an agreement to be acquired by BTG Plc (LSE:BTG) in a deal worth up to ...
BTG to buy US lung device company for up to $475 million  Reuters UK
Related articles »  
BTG plc Receives Overweight Rating from JPMorgan Chase & Co.
BTG plc (LON:BTG)'s stock had its �overweight� rating reissued by investment analysts at JPMorgan Chase & Co. in a note issued to investors on Friday.
BTG plc PT Raised to GBX 1030 (BTG)  WKRB News
Investec Increases BTG plc Price Target to GBX 1135 (LON:BTG)  The Legacy
Weekly Investment Analysts' Ratings Changes for BTG plc (BTG)
BTG plc had its �buy� rating reaffirmed by analysts at Panmure Gordon. They now have a GBX 750 ($11.68) price target on the stock.
BTG plc Price Target Increased to GBX 1000 by Analysts at Deutsche Bank (BTG)  WKRB News
BTG plc PT Raised to GBX 1000 (BTG)  Ticker Report
Related articles »  
Deutsche Bank Raises BTG plc Price Target to GBX 1030 (BTG)
BTG plc logo BTG plc (LON:BTG) had its price target increased by Deutsche Bank from GBX 1,000 ($15.14) to GBX 1,030 ($15.59) in a research report sent to investors on Thursday morning.